Dr. Agarwal's Health Care: Receipt of sanction from the Honble NCLT, Chennai Bench towards the scheme of amalgamation between Dr.…

What happened

Dr. Agarwal's Health Care (AGARWALEYE) filed a disclosure with the exchanges on 5 October 2026 at 10:40 PM titled "Receipt of sanction from the Honble NCLT, Chennai Bench towards the scheme of amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and…".

Company snapshot

Dr. Agarwal's Health Care is a small-cap company in the Healthcare sector, with a market value of about ₹15,420 crore.

The stock last traded at ₹486.5, against a 52-week range of ₹401–₹568 (14.4% below the high).

Before this filing the shares had moved −4.4% over the month and +1.9% over three months. Average daily turnover over the last 20 sessions was about ₹15.09 crore.

Promoters held 32.34% at the end of Q1 FY27, down 0.02% points from the previous quarter. Foreign institutions owned 57.96% and domestic institutions 7.72%.

What history shows

BCEIE's records show 3 previous m&a filings from the company since May 2026.

Across 124 similar disclosures by other Healthcare companies, shares moved +0.8% on average the next day and +1.3% over five days; 61% of them rose the next day.

Market-wide, 1,961 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Regulatory approvals, completion of the deal and its effect on revenue and margins.

Source

• Exchange filing (PDF)